In a nutshell This phase 3 trial is examining the effectiveness of vibegron in the treatment of overactive bladder symptoms (OAB) in patients with prostatic hyperplasia (BPH; enlarged prostatic gland). The main outcome of this trial will be a change in urgency episodes. This trial is being conducted in the US and Canada. The details A benign (not...
Read MoreAdditional medical conditions-Nocturia Posts on Medivizor
Is silodosin effective for the treatment of nocturia in men with benign prostatic hyperplasia?
In a nutshell This study aimed to investigate the safety and effectiveness of silodosin (Rapaflo, Silodyx) for the treatment of nocturia in men with benign prostatic hyperplasia (BPH). This study found that silodosin is safe and effective for the treatment of nocturia in these patients. Some background People diagnosed with BPH...
Read More